Drug firm Granules India announced on Friday its acquisition of Swiss CDMO company Senn Chemicals AG for CHF 20 million (approximately Rs 192 crore). This strategic acquisition is aimed at bolstering Granules India’s foothold in the peptide therapeutics market.
